M&T Bank’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

M&T Bank’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-17,150	Closed	-$291K	–	2232
2014 Q4	$291K	Sell	17,150 -3,560	-17%	-$50.1K	﹤0.01%	1512
2014 Q3	$247K	Buy	+20,710	New	+$141K	﹤0.01%	1714

M&T Bank's AVNR Position: Q1 2015 in Review

M&T Bank sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 17,150 shares — an estimated $291K sold.

M&T Bank first reported a position in AVNR in Q3 2014 and held it in 2 quarters. The position peaked at $291K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

M&T Bank reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
M&T Bank sold 17,150 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $291K.
M&T Bank first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2014 and held it in 2 quarters.
M&T Bank's AVANIR PHARMACEUTICALS, INC CL A position peaked at $291K in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on M&T Bank's 13F filing for Q1 2015, filed 14 May 2015.